SCOR Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 5/6
SCOR verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 23%, während die Gewinne der Branche Insurance jährlich um gewachsen und zwar um 13.3%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von rückläufig von 2%. Die Eigenkapitalrendite von SCOR beträgt 13.3% und die Nettomargen betragen 5.7%.
Wichtige Informationen
22.97%
Wachstumsrate der Gewinne
23.69%
EPS-Wachstumsrate
| Insurance Wachstum der Industrie | 11.75% |
| Wachstumsrate der Einnahmen | -1.95% |
| Eigenkapitalrendite | 13.28% |
| Netto-Marge | 5.66% |
| Nächste Ertragsaktualisierung | 30 Jul 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
SCR: Rising Street Confidence And Dividend Policy Will Shape Future Balance
SCOR's updated analyst price target edges up from €33.00 to about €33.86, reflecting analysts' recent target increases at several banks. These increases point to slightly higher fair value and P/E assumptions, despite more cautious revenue growth inputs.SCR: Higher Street Expectations And Dividend Plans Will Shape Future Balance
SCOR's updated analyst price target edges higher to about €33, supported by recent Street research that has moved targets into a €34 to €38 range as analysts refine assumptions around discount rate, profit margin and future P/E. Analyst Commentary Recent Street research on SCOR has centered on higher price targets, with several bullish analysts revisiting their assumptions on discount rates, profitability and acceptable P/E levels for the stock.SCR: Mixed Rating Shifts And New CFO Appointment Will Shape Future Balance
The analyst price target for SCOR has been revised slightly higher, with the fair value estimate moving from approximately €32.74 to about €33.01. This adjustment is supported by a series of recent target increases from banks such as Berenberg, Morgan Stanley and Citi, along with an upgrade at BNP Paribas.SCR: Mixed Rating Shifts And New CFO Appointment Will Shape Balanced Outlook
SCOR's updated analyst price target edges higher to €32.74 from €31.98, with analysts citing refreshed models that reflect revised growth and margin assumptions, a modestly higher future P/E multiple, and a series of recent target increases from major banks. Analyst Commentary Recent research updates point to a mixed but generally constructive stance on SCOR, with several price target revisions clustered in the low to mid €30s and one higher target in the high €30s.SCR: Mixed Rating Shifts And New CFO Appointment Shape Balanced Outlook
Analysts have lifted their implied price target on SCOR from about €31.74 to roughly €32, pointing to a slightly higher fair value as they factor in updated growth assumptions and recent target hikes from several banks alongside one downgrade. Analyst Commentary Recent research updates on SCOR reflect a mixed but generally constructive tone, with several firms lifting price targets while one high profile bank has turned more cautious.SCR: Balanced Outlook As Execution And New CFO Transition Guide Rerating Potential
Analysts have nudged their price target on SCOR higher to €32. The modest change reflects a mix of recent target increases, such as Berenberg's €1.50 uplift, and offsetting caution from other firms, all incorporated into updated valuation assumptions.SCR: Execution On Earnings And New CFO Appointment Will Shape Rerating Potential
Analysts have trimmed their price target on SCOR from €32.00 to about €31.74, reflecting slightly lower fair value and profit margin assumptions alongside modestly reduced future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts highlight the recent upgrade to Outperform as a sign that current valuation is seen as reasonable relative to their €32 price target.SCR: Reinsurance Execution And Earnings Quality Will Support Future Rerating
Analysts have inched their average price target for SCOR up to about €32, with small adjustments to discount rate, revenue growth, profit margin and future P/E, reflecting a more finely balanced view after recent rating changes and price target updates across the Street. Analyst Commentary Recent Street research on SCOR has sent mixed signals, with changes in ratings and modest adjustments to price targets clustering around the low €30s.SCR: Reinsurance Pricing And Margin Discipline Will Support Future Rerating
Narrative Update: Analyst Price Targets for SCOR Analysts now see SCOR's price target clustered in the low to mid €30s, with recent updates ranging from about €31.76 to €35 as they adjust their views using broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent target changes for SCOR cluster between about €31.76 and €35.SCR: Rising Reinsurance Pricing And Margin Discipline Will Support Future Upside
The analyst price target for SCOR has edged higher to EUR 31.76 from EUR 31.98, as analysts factor in a slightly lower discount rate, marginally improved profit margin expectations, and supportive upward target revisions from major brokerage houses. Analyst Commentary Recent Street research reflects a generally constructive stance on SCOR, with multiple upward revisions to price targets alongside one modest downgrade.SCR: Rising Reinsurance Pricing And Margin Discipline Will Drive Future Performance
Analysts have nudged their average price target on SCOR slightly lower to about EUR 31.76 from roughly EUR 31.98. This reflects modestly higher discount rate assumptions even as they remain broadly constructive on the shares.SCR: Recent Margin Gains And Improved Outlook Will Drive Future Performance
SCOR's analyst price target has increased modestly from €31.24 to €31.98. Analysts cite slight improvements in profit margin expectations and a supportive outlook from recent Street research as key factors behind the revision.SCR: Improved Margins And Upward Revisions Will Drive Future Share Outperformance
The analyst consensus price target for SCOR fell slightly from €31.998 to €31.244, as analysts cited modestly lower revenue growth projections. This was balanced against improved profit margins and valuation multiples.Analyst Commentary Highlights Rising Confidence in SCOR Amid Upward Revisions and Improved Valuation Metrics
SCOR's analyst price target has increased from €31.36 to €31.99. This change reflects recent analyst confidence in improved profit margins and revenue growth forecasts.Investors Holding Back On SCOR SE (EPA:SCR)
SCOR SE's ( EPA:SCR ) price-to-earnings (or "P/E") ratio of 10.3x might make it look like a buy right now compared to...Elevated Climate Risk And Diversification Will Unlock Reinsurance Value
Analysts have modestly increased their price target for SCOR from $30.81 to $31.36. They cite improved profit margin expectations and a lower discount rate as key factors supporting the upward revision.
Forward 2026 And Decisive P&C Initiatives Poised To Restore Profitability And Boost Earnings
Successful strategic plan and assumption reviews could restore profitability and stabilize future returns through improved business strategies.Aufschlüsselung der Einnahmen und Ausgaben
Wie SCOR Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 15,477 | 876 | 0 | 0 |
| 31 Dec 25 | 15,689 | 851 | 0 | 0 |
| 30 Sep 25 | 16,159 | 875 | 0 | 0 |
| 30 Jun 25 | 16,151 | 541 | 0 | 0 |
| 31 Mar 25 | 16,340 | 8 | 0 | 0 |
| 31 Dec 24 | 16,460 | 4 | 0 | 0 |
| 30 Sep 24 | 15,593 | -67 | 0 | 0 |
| 30 Jun 24 | 15,080 | 198 | 0 | 0 |
| 31 Mar 24 | 16,353 | 697 | 0 | 0 |
| 31 Dec 23 | 16,242 | 812 | 0 | 0 |
| 30 Sep 23 | 20,065 | 1,376 | 0 | 0 |
| 30 Jun 23 | 15,869 | -606 | 0 | 0 |
| 31 Mar 23 | 19,563 | 45 | 0 | 0 |
| 31 Dec 22 | 15,984 | -1,383 | 0 | 0 |
| 30 Sep 22 | 16,791 | -910 | 0 | 0 |
| 30 Jun 22 | 17,180 | -199 | 0 | 0 |
| 31 Mar 22 | 17,810 | 331 | 0 | 0 |
| 01 Jan 22 | 17,675 | 456 | 0 | 0 |
| 30 Sep 21 | 16,373 | 438 | 0 | 0 |
| 30 Jun 21 | 16,890 | 588 | 0 | 0 |
| 31 Mar 21 | 16,834 | 117 | 0 | 0 |
| 31 Dec 20 | 16,973 | 234 | 0 | 0 |
| 30 Sep 20 | 16,938 | 156 | 0 | 0 |
| 30 Jun 20 | 16,952 | 162 | 0 | 0 |
| 31 Mar 20 | 16,818 | 453 | 0 | 0 |
| 31 Dec 19 | 16,546 | 422 | 0 | 0 |
| 30 Sep 19 | 16,157 | 381 | 0 | 0 |
| 30 Jun 19 | 16,114 | 346 | 0 | 0 |
| 31 Mar 19 | 15,762 | 287 | 0 | 0 |
| 31 Dec 18 | 15,639 | 322 | 0 | 0 |
| 30 Sep 18 | 15,404 | 603 | 0 | 0 |
| 30 Jun 18 | 15,340 | 256 | 0 | 0 |
| 31 Mar 18 | 15,339 | 312 | 0 | 0 |
| 31 Dec 17 | 15,334 | 286 | 0 | 0 |
| 30 Sep 17 | 15,126 | 190 | 0 | 0 |
| 30 Jun 17 | 15,036 | 620 | 0 | 0 |
| 31 Mar 17 | 14,715 | 573 | 0 | 0 |
| 31 Dec 16 | 14,369 | 603 | 0 | 0 |
| 30 Sep 16 | 14,251 | 588 | 0 | 0 |
| 30 Jun 16 | 14,191 | 590 | 0 | 0 |
| 31 Mar 16 | 14,089 | 637 | 0 | 0 |
| 31 Dec 15 | 13,930 | 642 | 0 | 0 |
| 30 Sep 15 | 13,296 | 627 | 0 | 0 |
| 30 Jun 15 | 12,874 | 583 | 0 | 0 |
Qualität der Erträge: SCR hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: SCRDie aktuellen Gewinnspannen (5.7%) sind höher als im letzten Jahr (0.05%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: SCRIn den letzten 5 Jahren sind die Einnahmen von 23% pro Jahr erheblich gestiegen.
Beschleunigtes Wachstum: SCRDas Gewinnwachstum des Unternehmens im letzten Jahr (10850%) übertrifft seinen 5-Jahres-Durchschnitt (23% pro Jahr).
Erträge im Vergleich zur Industrie: SCR Das Gewinnwachstum im vergangenen Jahr (10850%) übertraf das der Branche Insurance 20.6% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: SCRDie Eigenkapitalrendite des Unternehmens (13.3%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 13:32 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
SCOR SE wird von 31 Analysten beobachtet. 11 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Daniel Bischof | Baader Helvea Equity Research |
| Ivan Bokhmat | Barclays |
| Michael Huttner | Berenberg |